drugset / Trial / NCT02642380
Different Cycles of High-dose Dexamethasone for Initial Management of Primary Immune Thrombocytopenia (ITP)
RandomizedParallel-groupOpen-labelTreatment
Summary
The project was organized by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of different cycles of high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).
Timeline
- Start
- 2015-11
- Primary completion
- 2018-11
- Completion
- 2018-11
Outcome
Outcome not reported
Stopped (Enrollment): “No eligible patient was enrolled.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 40 mg | Oral |